KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dorman Products (DORM) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Dorman Products (DORM) over the last 16 years, with Q3 2025 value amounting to $10.4 million.

  • Dorman Products' Capital Expenditures rose 2136.76% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year decrease of 1013.08%. This contributed to the annual value of $39.4 million for FY2024, which is 1034.16% down from last year.
  • According to the latest figures from Q3 2025, Dorman Products' Capital Expenditures is $10.4 million, which was up 2136.76% from $8.4 million recorded in Q2 2025.
  • Over the past 5 years, Dorman Products' Capital Expenditures peaked at $14.1 million during Q4 2022, and registered a low of $3.9 million during Q2 2021.
  • Over the past 5 years, Dorman Products' median Capital Expenditures value was $8.9 million (recorded in 2022), while the average stood at $9.0 million.
  • In the last 5 years, Dorman Products' Capital Expenditures soared by 20886.99% in 2022 and then crashed by 2919.98% in 2025.
  • Quarter analysis of 5 years shows Dorman Products' Capital Expenditures stood at $4.6 million in 2021, then skyrocketed by 208.87% to $14.1 million in 2022, then fell by 21.78% to $11.0 million in 2023, then dropped by 25.89% to $8.2 million in 2024, then grew by 26.99% to $10.4 million in 2025.
  • Its Capital Expenditures stands at $10.4 million for Q3 2025, versus $8.4 million for Q2 2025 and $11.0 million for Q1 2025.